| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 18,984 | 12,657 | ||
| Other receivables | 217 | 217 | ||
| Prepaid expenses and other current assets | 160 | 172 | ||
| Property, plant and equipment, held for sale | 0 | 0 | ||
| Total current assets | 19,361 | 13,046 | ||
| Property, plant and equipment, net | 0 | 0 | ||
| Other assets | 0 | 0 | ||
| Operating lease right-of-use asset, net | 0 | 0 | ||
| Total assets | 19,361 | 13,046 | ||
| Accounts payable and accrued expenses | 6,911 | 7,500 | ||
| Payables and accrued expenses - related party | 2,529 | 2,504 | ||
| Operating lease liabilities - short-term | 0 | 0 | ||
| Total current liabilities | 9,440 | 10,004 | ||
| Deferred income | 150 | 150 | ||
| Operating lease liabilities - long-term | 0 | 0 | ||
| Total liabilities | 9,590 | 10,154 | ||
| Common stock (0.0001 par value), 200,000,000 shares authorized as of september 30, 2025 and december 31, 2024, respectively-Common Unspecified Class | 1 | - | ||
| Common stock issuable, zero and 69,046 shares as of september 30, 2025 and december 31, 2024, respectively | 0 | 0 | ||
| Additional paid-in capital | 407,876 | 400,530 | ||
| Accumulated deficit | -398,106 | -397,638 | ||
| Total stockholders' equity (deficit) | 9,771 | 2,892 | ||
| Total liabilities and stockholders' equity (deficit) | 19,361 | 13,046 | ||
MUSTANG BIO, INC. (MBIO)
MUSTANG BIO, INC. (MBIO)